7Baggers
 Published on: 2025-10-02 23:30:57  newser.com Fri, 03 Oct 2025 04:30:57 GMT
 published on: 2025-10-02 19:03:17  newser.com Fri, 03 Oct 2025 00:03:17 GMT
 published on: 2025-09-30 20:29:52  newser.com Wed, 01 Oct 2025 01:29:52 GMT
 Published on: 2025-09-29 00:44:31  newser.com Mon, 29 Sep 2025 05:44:31 GMT
 NeuroSense Therapeutics Approves Resolutions at Annual Meeting  TipRanks Thu, 25 Sep 2025 13:50:54 GMT
 published on: 2025-09-22 08:53:14  newser.com Mon, 22 Sep 2025 13:53:14 GMT
 health care stocks tumble while neurosense defies the drop  Finimize Thu, 11 Sep 2025 12:35:28 GMT
 LGC opens $72M chemical plant; Recipharm partners with NeuroSense  Endpoints News Thu, 11 Sep 2025 07:00:00 GMT
 health care stocks tumble while neurosense defies the drop  Finimize Wed, 10 Sep 2025 21:32:58 GMT
 sector update: health care  富途牛牛 Wed, 10 Sep 2025 19:29:13 GMT
 neurosense therapeutics (nrsn) stock price, news & analysis  MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 06:57:02  Newser Thu, 04 Sep 2025 11:57:02 GMT
 published on: 2025-09-04 04:02:37  Newser Thu, 04 Sep 2025 09:02:37 GMT
 published on: 2025-09-03 00:51:52  Newser Wed, 03 Sep 2025 05:51:52 GMT
 published on: 2025-09-02 23:48:18  Newser Wed, 03 Sep 2025 04:48:18 GMT
 published on: 2025-09-02 14:40:21  Newser Tue, 02 Sep 2025 19:40:21 GMT

NeuroSense Therapeutics Ltd.
(NASDAQ:NRSN) 

NRSN stock logo

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin an...

Founded: 2017
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends